<DOC>
	<DOCNO>NCT02596256</DOCNO>
	<brief_summary>Apatinib plus docetaxel versus docetaxel second-line treatment advance gastric cancer .</brief_summary>
	<brief_title>Apatinib Plus Docetaxel Versus Docetaxel Second-line Treatment Advanced Gastric Cancer ( AHEAD-301 )</brief_title>
	<detailed_description>This trial investigate safety efficacy apatinib plus docetaxel , treatment option heavily pretreated patient advanced gastric cancer .</detailed_description>
	<mesh_term>Stomach Neoplasms</mesh_term>
	<mesh_term>Docetaxel</mesh_term>
	<criteria>1 . Age : 18 year old , male female ; 2 . Pathologically diagnose advanced gastric cancer ( include adenocarcinoma gastroesophageal junction ) measurable metastasis outside stomach ( measure ≥ 10mm spiral compute tomography ( CT ) scan , satisfy criterion Response Evaluation Criteria In Solid Tumors ( RECIST ) 1.1 ) ; 3 . Failure prior therapy ( treatment ) patient receive first line chemotherapy regimen ( platinum base regimen ) ; 4 . Eastern Cooperative Oncology Group Performance Status ( ECOG PS ) 01 ; 5 . Major organ function meet follow criterion ; ( 1 ) For result blood routine test biochemical test : 1 . Hemoglobin ( HB ) ≥ 80g / L , 2 . ANC ≥ 1.5 × 109 / L , 3 . PLT ≥ 90 × 109 / L , 4 . ALT AST ≤ 2.5 × ULN , liver metastasis , , ALT AST≤5 × ULN , 5 . Bilirubin ≤ 1.5 time upper limit normal ( ULN ) , 6 . Serum creatinine ≤ 1.5 time upper limit normal ( ULN ) , 7 . Serum albumin ≥ 30g / L ; 6 . An expected survival ≥ 3 month ; 7 . Pregnancy test ( serum urine ) perform woman childbearing age within 7 day enrolment test result must negative . They shall take appropriate method contraception study 8th week post last administration study drug . For men , ( previous surgical sterilization accept ) , shall agree take appropriate method contraception study 8th week post last administration study drug ; 8 . Patient voluntarily join study sign Informed Consent Form study . 1 . Confirmed apatinib and/or accessory allergy ; 2 . Subjects poorcontrolled arterial hypertension ( systolic blood pressure &gt; 140 mmHg diastolic blood pressure &gt; 90 mm Hg ) despite standard medical management ; Coronary heart disease great Class Ⅰ ; Ⅰlevel arrhythmia ( include QT interval prolongation , man ≥ 450 m , woman ≥ 470 m ) together Class Ⅰ cardiac dysfunction ; Patients positive urinary protein ; 3 . Factors could effect oral medication ( inability swallow , chronic diarrhea intestinal obstruction ) ; 4 . Subjects high gastrointestinal bleeding risk , include follow condition : local active ulcer lesion positive fecal occult blood test ( ++ ) ; history black stool , vomit blood past 2 month ; unresected primary lesion stomach positive fecal occult blood test ( + ) , ulcerated gastric carcinoma massive alimentary tract bleed risk judge PIs base gastric endoscopy result ; 5 . Abnormal Coagulation ( INR &gt; 1.5、APTT &gt; 1.5 UNL ) , tendency bleed ; 6 . Associated CNS ( central nervous system ) metastases ; 7 . Pregnant lactating woman ; 8 . Pts malignant tumor within 5 year ; 9 . With psychotropic drug abuse history ca n't get rid mental disorder patient ; 10 . Participated clinical trial within 4 week ; 11 . Pts receive VEGFR inhibitor treatment ( i.e . sorafenib , sunitinib ) ; 12 . Any condition might place patient undue risk preclude patient completing study ; 13 . Other condition regiment investigator ' discretion .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2016</verification_date>
</DOC>